158 related articles for article (PubMed ID: 19916076)
1. [The S3 guideline exocrine pancreatic cancer].
Seufferlein T; Adler G
Med Klin (Munich); 2009 Nov; 104(11):869-74. PubMed ID: 19916076
[TBL] [Abstract][Full Text] [Related]
2. [New aspects of surgery for pancreatic cancer. Principles, results and evidence].
Distler M; Grützmann R
Pathologe; 2012 Nov; 33 Suppl 2():258-65. PubMed ID: 23108784
[TBL] [Abstract][Full Text] [Related]
3. The treatment of pancreatic cancer.
Yeo CJ; Cameron JL
Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793
[No Abstract] [Full Text] [Related]
4. [Surgery of malignant pancreatic tumors].
Loos M; Friess H; Kleeff J
Radiologe; 2009 Feb; 49(2):137-43. PubMed ID: 19153706
[TBL] [Abstract][Full Text] [Related]
5. Strategies to improve the outcome in locally advanced pancreatic cancer.
Späth C; Nitsche U; Müller T; Michalski C; Erkan M; Kong B; Kleeff J
Minerva Chir; 2015 Apr; 70(2):97-106. PubMed ID: 25658301
[TBL] [Abstract][Full Text] [Related]
6. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
7. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
8. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
9. The Use of Biomarkers in Early Diagnostics of Pancreatic Cancer.
Kunovsky L; Tesarikova P; Kala Z; Kroupa R; Kysela P; Dolina J; Trna J
Can J Gastroenterol Hepatol; 2018; 2018():5389820. PubMed ID: 30186820
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival.
Marangos IP; Buanes T; Røsok BI; Kazaryan AM; Rosseland AR; Grzyb K; Villanger O; Mathisen Ø; Gladhaug IP; Edwin B
Surgery; 2012 May; 151(5):717-23. PubMed ID: 22284762
[TBL] [Abstract][Full Text] [Related]
11. [Short- and long-term results in operable pancreatic ductal adenocarcinomas from a cooperation between two departments gastroenterology-visceral surgery at non-university hospitals benchmarked to results of expert-centers].
Dippold W; Sivanathan V; Statt K; Roitman M; Link KH
Z Gastroenterol; 2017 Feb; 55(2):140-144. PubMed ID: 27875849
[TBL] [Abstract][Full Text] [Related]
12. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
13. [Exocrine pancreatic cancer - what is new in the update of the S3 guideline?].
Seufferlein T; Kestler A
Dtsch Med Wochenschr; 2023 Jun; 148(12):737-743. PubMed ID: 37257475
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
Grossberg AJ; Chu LC; Deig CR; Fishman EK; Hwang WL; Maitra A; Marks DL; Mehta A; Nabavizadeh N; Simeone DM; Weekes CD; Thomas CR
CA Cancer J Clin; 2020 Sep; 70(5):375-403. PubMed ID: 32683683
[TBL] [Abstract][Full Text] [Related]
15. Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy.
Syed AR; Carleton NM; Horne Z; Dhawan A; Bedi G; Kochhar G; Morrissey S; Williams H; Atkinson D; Schiffman S; Monga D; Lupetin A; Kirichenko A; Mitre M; Dhawan M; Kulkarni A; Thakkar S
J Gastrointest Cancer; 2020 Sep; 51(3):836-843. PubMed ID: 31605289
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
Alemi F; Alseidi A; Scott Helton W; Rocha FG
Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
[No Abstract] [Full Text] [Related]
17. Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study.
Guo JC; Zhang P; Zhou L; You L; Liu QF; Zhang ZG; Sun B; Liang ZY; Lu J; Yuan D; Tan AD; Sun J; Liao Q; Dai MH; Xiao GG; Li S; Zhang TP
EBioMedicine; 2020 May; 55():102767. PubMed ID: 32361251
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy.
Kato K; Kondo S; Hirano S; Tanaka E; Shichinohe T; Tsuchikawa T; Matsumoto J
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):712-6. PubMed ID: 21455748
[TBL] [Abstract][Full Text] [Related]
19. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
20. [Cystic pancreatic tumors: diagnostics and new biomarkers].
Berger AW; Seufferlein T; Kleger A
Chirurg; 2017 Nov; 88(11):905-912. PubMed ID: 28831506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
